APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
OBJECTIVE
The APOE genotype and serum calcium levels have both been associated with cognitive impairment. Animal studies have shown variation in apoE isoforms to play a critical role in intraneuronal calcium homeostasis, but the contribution of this interaction to cognitive function in man is unknown. Here, we studied whether the APOE genotype modulates the association between serum calcium levels and cognition.


METHODS
Within the Leiden 85-plus Study, a prospective population-based study of 599 subjects aged 85 years, we measured serum calcium levels and APOE genotype at baseline. During a 5-year follow-up period, cognitive function was annually assessed using the Mini-Mental State Examination (MMSE) and a standardized neuropsychological test battery.


RESULTS
Both at baseline and during follow-up, high serum calcium levels were associated with worse cognitive function in epsilon3epsilon4 carriers and to a lesser extent in epsilon3epsilon3 carriers, but not in epsilon2epsilon3 carriers. The MMSE score during the entire follow-up period differed between those with high and low serum calcium levels, with 5.5 points in epsilon3epsilon4 carriers (p < 0.001), 1.6 points in epsilon3epsilon3 carriers (p = 0.010), and 0.1 point in epsilon2epsilon3 carriers (p = 0.935). Formal testing showed an interaction between APOE genotype and serum calcium levels in relation to global cognitive function (p = 0.003).


CONCLUSIONS
In old age, APOE genotype modulates the association between serum calcium levels and cognitive function. High serum calcium levels associate with worse cognitive function, especially in APOE epsilon4 allele carriers, but not in carriers of the epsilon2 allele.
van Vliet
P
P
Leiden University Medical Center, Department of Gerontology and Geriatrics (C2-R), Leiden, The Netherlands. p.van_vliet@lumc.nl
Oleksik
A M
AM
Mooijaart
S P
SP
de Craen
A J M
AJ
Westendorp
R G J
RG
D000369:Aged, 80 and over; D000375:Aging / Q000097:blood* / Q000235:genetics* / Q000523:psychology; D000483:Alleles; D053329:Apolipoprotein E2 / Q000235:genetics*; D053327:Apolipoprotein E4 / Q000235:genetics*; D015415:Biomarkers / Q000097:blood; D002118:Calcium / Q000097:blood*; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000097:blood* / Q000235:genetics* / Q000523:psychology; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D008297:Male; D011446:Prospective Studies
D053329:Apolipoprotein E2; D053327:Apolipoprotein E4; D015415:Biomarkers; D002118:Calcium